Your browser doesn't support javascript.
loading
Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster.
Torres, Montserrat; Corona, Magdalena; Rodríguez-Mora, Sara; Casado-Fernández, Guiomar; Zurdo-Castronuño, Alejandro; Mateos, Elena; Ramos-Martín, Fernando; Sánchez-Menéndez, Clara; Murciano-Antón, María Aranzazú; García-Pérez, Javier; Alcamí, José; Pérez-Olmeda, Mayte; Coiras, Mayte; López-Jiménez, Javier; García-Gutiérrez, Valentín.
Afiliación
  • Torres M; Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, 28220 Majadahonda, Spain.
  • Corona M; Hematology and Hemotherapy Service, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
  • Rodríguez-Mora S; Hematology and Hemotherapy Service, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
  • Casado-Fernández G; Faculty of Sciences, Universidad de Alcalá, 28871 Alcalá de Henares, Spain.
  • Zurdo-Castronuño A; Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, 28220 Majadahonda, Spain.
  • Mateos E; Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, 28220 Majadahonda, Spain.
  • Ramos-Martín F; Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, 28220 Majadahonda, Spain.
  • Sánchez-Menéndez C; Faculty of Sciences, Universidad de Alcalá, 28871 Alcalá de Henares, Spain.
  • Murciano-Antón MA; Hematology and Hemotherapy Service, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
  • García-Pérez J; Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, 28220 Majadahonda, Spain.
  • Alcamí J; Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, 28220 Majadahonda, Spain.
  • Pérez-Olmeda M; Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, 28220 Majadahonda, Spain.
  • Coiras M; Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, 28220 Majadahonda, Spain.
  • López-Jiménez J; Family Medicine, Centro de Salud Doctor Pedro Laín Entralgo, 28924 Alcorcón, Spain.
  • García-Gutiérrez V; Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, 28220 Majadahonda, Spain.
  • On Behalf Of The Multidisciplinary Group Of Study Of Covid-Mgs-Covid; AIDS Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, 28222 Majadahonda, Spain.
Cancers (Basel) ; 14(22)2022 Nov 10.
Article en En | MEDLINE | ID: mdl-36428631

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article